Does noninvasive ventilation delivery in the ward provide early effective ventilation?

Respir Care

Department of Translational Medicine, Università del Piemonte Orientale Amedeo Avogadro, Novara Anesthesia and Intensive Care, Sant'Andrea Hospital, Vercelli; and with CRRF Mons. L. Novarese, Moncrivello, Vercelli, Italy.

Published: January 2015

Background: Although noninvasive ventilation (NIV) is increasingly used in general wards, limited information exists about its ability to provide effective ventilation in this setting. We aim to evaluate NIV delivered in the ward by assessing (1) overall time of application and occurrence of adverse events and (2) differences between daytime and nighttime NIV application.

Methods: We studied subjects with hypercapnic acute hypercapnic respiratory failure not fulfilling strict criteria for ICU admission, and excluded those who interrupted NIV prior to 48 h. Time spent on NIV, presence and extent of air leaks, and occurrence of desaturations were assessed for the overall study period, and compared between daytime and nighttime.

Results: We enrolled 42 subjects, 25 of whom received NIV for at least 48 h and were included in the data analysis. NIV was successful for 20 subjects, who did not reach criteria for ICU admission. Both PaCO2 and pH significantly improved on average after 2 h and at the end of the study period. NIV was applied for 64.5% of the overall study period and had absent or compensated air leaks for 62.3% of the overall 48-h period. NIV was applied for 55.8% of daytime and for 79.3% of nighttime (P < .01). Effective NIV application was significantly longer overnight (76.9%) than during daytime (53.2%) (P < .01).

Conclusions: In selected subjects with hypercapnic acute respiratory failure not fulfilling criteria for ICU admission, the application of NIV in the ward is feasible; in addition, NIV can be safely administered overnight.

Download full-text PDF

Source
http://dx.doi.org/10.4187/respcare.03294DOI Listing

Publication Analysis

Top Keywords

niv
12
criteria icu
12
icu admission
12
study period
12
noninvasive ventilation
8
subjects hypercapnic
8
hypercapnic acute
8
respiratory failure
8
failure fulfilling
8
air leaks
8

Similar Publications

Purpose: The purpose of the study was to investigate the accuracy of complete-arch intraoral scans for all-on-4 implant treatment under simulated intraoral variables.

Materials And Methods: A maxillary model designed to receive 4 implants in the regions of first molars and canines was used. Intraoral digital scans were completed in a simulation device by simulating two2 different clinical conditions: normal intraoral variables (NIV) and limited intraoral variables (LIV).

View Article and Find Full Text PDF

Development of nebulized inhalation delivery for fusion-inhibitory lipopeptides to protect non-human primates against Nipah-Bangladesh infection.

Antiviral Res

January 2025

CIRI, Centre International de Recherche en Infectiologie, INSERM U1111, CNRS, UMR5308, Univ Lyon, Université Claude Bernard Lyon 1, École Normale Supérieure de Lyon, 21 Avenue Tony Garnier, 69007 Lyon, France.

Nipah virus (NiV) is a lethal zoonotic paramyxovirus that can be transmitted from person to person through the respiratory route. There are currently no licensed vaccines or therapeutics. A lipopeptide-based fusion inhibitor was developed and previously evaluated for efficacy against the NiV-Malaysia strain.

View Article and Find Full Text PDF

Improving clinical care of patients in Nipah outbreaks: moving beyond 'compassionate use'.

Lancet Reg Health Southeast Asia

February 2025

Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

The 2024 Nipah outbreak in Kerala, India-its fifth in six years-and the recurring annual outbreaks in Bangladesh underscore the persistent threat posed by the Nipah virus (NiV) in the region. With a high mortality rate, human-to-human transmission potential, and the widespread presence of bats, the natural reservoir, NiV remains a significant epidemic threat. Despite being a WHO priority pathogen, there has been no systematic effort to improve patient care for NiVD, leading to consistently poor outcomes.

View Article and Find Full Text PDF

Background: Acute kidney injury (AKI) is common in critically ill patients and is associated with increased morbidity and mortality. Its complications often require renal replacement therapy (RRT). Invasive mechanical ventilation (IMV) and infections are considered risk factors for the occurrence of AKI.

View Article and Find Full Text PDF

Nipah virus (NiV) is a zoonotic pathogen with the potential to cause human outbreaks with a high case fatality ratio. In this systematic review and meta-analysis, available evidence on NiV infections occurring in healthcare workers (HCWs) was collected and critically appraised. According to the PRISMA statement, four medical databases (PubMed, CINAHL, EMBASE, and Scopus) and the preprint repository medRixv were inquired through a specifically designed searching strategy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!